AIM ImmunoTech
15 hedge funds and large institutions have $294K invested in AIM ImmunoTech in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
180% more capital invested
Capital invested by funds: $105K → $294K (+$189K)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
25% more funds holding
Funds holding: 12 → 15 (+3)
3.96% more ownership
Funds ownership: 0% → 3.96% (+4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$194K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$129K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$72.5K |
| 5 |
Morgan Stanley
New York
|
+$452 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corient Private Wealth
Miami,
Florida
|
-$86.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.93K |
| 3 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$26 |
AIM Hedge Fund Activity: Q3 2025 in Review
15 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2025, worth a combined $294K — up 180% from $105K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AIM positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $194K. The largest seller was Corient Private Wealth, exiting entirely with an estimated $86.5K sold.
- 15 institutional investors held AIM ImmunoTech (AIM) as of Q3 2025, up from 12 in Q2 2025.
- Funds reported $294K of AIM ImmunoTech stock for Q3 2025, up 180% quarter-over-quarter.
- 5 funds opened new AIM ImmunoTech positions in Q3 2025 and 2 closed out, a net change of +3 holders.
- The largest AIM ImmunoTech buyer in Q3 2025 was DRW Securities, an estimated $194K added.
- The largest AIM ImmunoTech seller in Q3 2025 was Corient Private Wealth, an estimated $86.5K sold.
Based on aggregated 13F filings for Q3 2025.